Response of cassava cultivars to African cassava mosaic virus infection across a range of inoculum doses and plant ages.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
08
2019
accepted:
03
12
2019
entrez:
24
12
2019
pubmed:
24
12
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Cassava production in Africa is constrained by cassava mosaic disease (CMD) that is caused by the Cassava mosaic virus (CMV). The aim of this study was to evaluate the responses of a range of commonly cultivated West African cassava cultivars to varying inoculum doses of African cassava mosaic virus (ACMV). We grafted 10 cultivars of cassava plants with different inoculum doses of CMV (namely two, four, or six CMD-infected buds) when the experimental plants were 8, 10, or 12 weeks old, using non-inoculated plants as controls. Three cultivars showed disease symptoms when grafted with two buds, and four cultivars showed disease symptoms when grafted with four or six buds. Most cultivars became symptomatic six weeks after inoculation, but one ('TMS92/0326') was symptomatic two weeks after inoculation, and two ('Ntollo' and 'Excel') were symptomatic after four weeks. Root weight tended to be lower in the six-bud than in the two-bud dose, and disease severity varied with plant age at inoculation. These results indicate that the level of CMD resistance in cassava cultivars varies with inoculum dose and timing of infection. This will allow appropriate cultivars to be deployed in each production zone of Africa in accordance with the prevalence of CMD.
Identifiants
pubmed: 31869401
doi: 10.1371/journal.pone.0226783
pii: PONE-D-19-24171
pmc: PMC6927654
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0226783Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Virol J. 2014 Dec 20;11:216
pubmed: 25526680
Theor Appl Genet. 2002 Sep;105(4):521-525
pubmed: 12582500
Virus Res. 2017 Jan 2;227:69-81
pubmed: 27693919
BMC Res Notes. 2013 Dec 06;6:516
pubmed: 24314370
J Gen Virol. 2001 Mar;82(Pt 3):655-65
pubmed: 11172108
Physiol Mol Plant Pathol. 2019 Jan;105:47-53
pubmed: 31007373
Adv Virus Res. 2006;67:355-418
pubmed: 17027685